PHASE I-II TRIAL OF ADOPTIVE IMMUNOTHERAPY WITH HAPLOIDENTICAL KIR LIGAND-MISMATCHED NATURAL KILLER CELLS IN HIGH RISK ACUTE MYELOBLASTIC LEUKEMIA PATIENTS

被引：0
|
作者：
Curti, A. [1 ,2 ]
Ruggeri, L. [3 ]
D'Addio, A. [1 ,2 ]
Urbani, E. [3 ]
Bontadini, A. [4 ,5 ]
Fruet, F. [4 ,5 ]
Giudice, V [4 ,5 ]
Dan, E. [1 ,2 ]
Motta, M. R. [1 ,2 ]
Rizzi, S. [1 ,2 ]
Paolini, S. [1 ,2 ]
Martinelli, G. [1 ,2 ]
Velardi, A. [3 ]
Baccarani, M. [1 ,2 ]
Lemoli, R. M. [1 ,2 ]
机构：
[1] Univ Bologna, Dept Hematol & Oncol L&A Seragnoli, Inst Hematol & Med Oncol L&A Seragnoli, Bologna, Italy
[2] St Orsola Marcello Malpighi Hosp, Stem Cell Res Ctr, Bologna, Italy
[3] Univ Perugia, IRCCS Fdn Transplantat Biotechnol, Div Hematol & Clin Immunol, Dept Clin Med, Perugia, Italy
[4] St Orsola Marcello Malpighi Hosp, Immunohematol Serv, Bologna, Italy
[5] St Orsola Marcello Malpighi Hosp, Blood Bank, Bologna, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P225
引用
下载
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [1] Phase I-II trial of adoptive immunotherapy with haploidentical KIR ligand-mismatched natural killer cells in high risk acute myeloblastic leukemia patients
    Curti, Antonio
    Ruggeri, Loredana
    D'Addio, Alessandra
    Urbani, Elena
    Bontadini, Andrea
    Fruet, Fiorenza
    Giudice, Valeria
    Dan, Elisa
    Motta, Maria Rosa
    Rizzi, Simona
    Paolini, Stefania
    Gugliotta, Gabriele
    Conte, Roberto
    Martinelli, Giovanni
    Velardi, Andrea
    Baccarani, Michele
    Lemoli, Roberto M.
    BLOOD, 2007, 110 (11) : 840A - 841A
  • [2] Phase I-II trial of adoptive immunotherapy with haploidentical KIR ligand-mismatched natural killer cells in high-risk acute myeloblastic leukaemia patients
    D'Addio, A.
    Curti, A.
    Ruggeri, L.
    Urbani, E.
    Bontadini, A.
    Fruet, F.
    Giudice, V.
    Dan, E.
    Motta, M. R.
    Rizzi, S.
    Paolini, S.
    Martinelli, G.
    Velardi, A.
    Baccarani, M.
    Lemoli, R. M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S72 - S72
  • [3] Phase I-II trial of adoptive immunotherapy with haploidentical KIR ligand-mismatched natural killer cells in high-risk acute myeloblastic leukaemia patients
    D'Addio, A.
    Curti, A.
    Ruggeri, L.
    Urbani, E.
    Bontadini, A.
    Fruet, F.
    Giudice, V.
    Dan, E.
    Motta, M. R.
    Rizzi, S.
    Paolini, S.
    Gugliotta, G.
    Conte, R.
    Martinelli, G.
    Velardi, A.
    Baccarani, M.
    Lemoli, R. M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S160 - S160
  • [4] Phase I-II trial of adoptive immunotherapy with haploidentical KIR ligand mismatched natural killer cells in high risk acute myeloblastic leukemia patients
    Curti, A.
    Ruggeri, L.
    D'Addio, A.
    Urbani, E.
    Bontadini, A.
    Fruet, F.
    Giudice, V
    Dan, E.
    MR, Motta
    Rizzi, S.
    Paolini, S.
    Gugliotta, G.
    Conte, R.
    Martinelli, G.
    Velardi, A.
    Baccarani, M.
    RM, Lemoli
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 12 - 13
  • [5] Adoptive immunotherapy with haploidentical KIR-ligand mismatched NK cells for acute myeloblastic leukemia patients
    Lemoli, Roberto. M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 37 - 37
  • [6] Adoptive Immunotherapy with Haploidentical Kir Ligand-Mismatched Natural Killer Cells In Elderly High Risk Acute Myeloid Leukemia Patients: Biological and Clinical Results of A Pilot Study.
    Curti, Antonio
    Ruggeri, Loredana
    D'Addio, Alessandra
    Bontadini, Andrea
    Giudice, Valeria
    Dan, Elisa
    Motta, Maria Rosa
    Rizzi, Simonetta
    Trabanelli, Sara
    Urbani, Elena
    Martinelli, Giovanni
    Paolini, Stefania
    Fruet, Fiorenza
    Isidori, Alessandro
    Casadei, Beatrice
    Bandini, Giuseppe
    Baccarani, Michele
    Velardi, Andrea
    Lemoli, Roberto M.
    BLOOD, 2010, 116 (21) : 1740 - 1740
  • [7] Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
    Curti, Antonio
    Ruggeri, Loredana
    D'Addio, Alessandra
    Bontadini, Andrea
    Dan, Elisa
    Motta, Maria Rosa
    Trabanelli, Sara
    Giudice, Valeria
    Urbani, Elena
    Martinelli, Giovanni
    Paolini, Stefania
    Fruet, Fiorenza
    Isidori, Alessandro
    Parisi, Sarah
    Bandini, Giuseppe
    Baccarani, Michele
    Velardi, Andrea
    Lemoli, Roberto M.
    BLOOD, 2011, 118 (12) : 3273 - 3279
  • [8] A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
    Nguyen, Rosa
    Wu, Huiyun
    Pounds, Stanley
    Inaba, Hiroto
    Ribeiro, Raul C.
    Cullins, David
    Rooney, Barbara
    Bell, Teresa
    Lacayo, Norman J.
    Heym, Kenneth
    Degar, Barbara
    Schiff, Deborah
    Janssen, William E.
    Triplett, Brandon
    Pui, Ching-Hon
    Leung, Wing
    Rubnitz, Jeffrey E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] LONG-TERM FOLLOW-UP OF ADOPTIVE IMMUNOTHERAPY WITH HAPLOIDENTICAL KIR-L MISMATCHED NATURAL KILLER CELLS AS POST-REMISSION CONSOLIDATION STRATEGY IN ELDERLY HIGH RISK ACUTE MYELOID LEUKEMIA PATIENTS
    Curti, A.
    Parisi, S.
    Ruggeri, L.
    D'Addio, A.
    Bontadini, A.
    Dan, E.
    Motta, M.
    Rizzi, S.
    Trabanelli, S.
    Giudice, V.
    Urbani, E.
    Martinelli, G.
    Paolini, S.
    Fruet, F.
    Bandini, G.
    Baccarani, M.
    Velardi, A.
    Lemoli, R.
    HAEMATOLOGICA, 2013, 98 : 412 - 412
  • [10] Novel strategies of adoptive immunotherapy: How natural killer cells may change the treatment of elderly patients with acute myeloblastic leukemia
    Lemoli, Roberto M.
    Parisi, Sarah
    Curti, Antonio
    EXPERIMENTAL HEMATOLOGY, 2017, 45 : 10 - 16
12345